Advertisement

Topics

Repare Therapeutics Raises US$68 Million Series A

05:00 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Novel cancer company founded by Versant Ventures Repare Therapeutics Inc. today announced a US$68 million Series A financing to advance its platform and pipeline of novel medicines that target genetically defined weaknesses ...

Other Sources for this Article

Versant Ventures
Steve Edelson, 415-801-8088
sedelson@versantventures.com

NEXT ARTICLE

More From BioPortfolio on "Repare Therapeutics Raises US$68 Million Series A"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...